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ABSTRACT
We characterised the human hSuv3p protein
belonging to the family of NTPases/helicases. In
yeast mitochondria the hSUV3 orthologue is a
component of the degradosome complex and
participates in mtRNA turnover and processing,
while in Caenorhabditis elegans the hSUV3 ortho-
logue is necessary for viability of early embryos.
Using immuno¯uorescence analysis, an in vitro
mitochondrial uptake assay and sub-fractionation of
human mitochondria we show hSuv3p to be a sol-
uble protein localised in the mitochondrial matrix.
We expressed and puri®ed recombinant hSuv3p
protein from a bacterial expression system. The
puri®ed enzyme was capable of hydrolysing ATP
with a Km of 41.9 mM and the activity was only
modestly stimulated by polynucleotides. hSuv3p
unwound partly hybridised dsRNA and dsDNA
structures with a very strong preference for the
latter. The presented analysis of the hSuv3p
NTPase/helicase suggests that new functions of the
protein have been acquired in the course of
evolution.
INTRODUCTION
Our research is focused on the structure and function of human
hSuv3p protein belonging to the class of putative ATP-
dependent RNA helicases from the DExH-box family.
Sequence database analyses imply that Suv3p is encoded by
a very ancient gene and highly conserved during evolution.
Orthologues have been found in, for example, Arabidopsis
thaliana, Caenorhabditis elegans, Drosophila melanogaster
and Homo sapiens. In Saccharomyces cerevisiae the hSUV3
orthologue encodes a subunit of the yeast mitochondrial
degradosome (also known as mtEXO), which exhibits 3¢®5¢
exoribonuclease activity in vitro (1). The degradosome
complex consists of two proteins encoded by nuclear genes
and is imported into mitochondria from the cytosol: the DSS1
gene codes for a protein with domains characteristic for RNase
II activity (2) while the SUV3 gene encodes a protein with a
putative RNA helicase activity (3). The SUV3 null mutant
lacks mtEXO RNase activity, which leads to abnormal
phenotypes associated with RNA metabolism, including
accumulation of excised group I introns, instability of
intron-containing and intronless mitochondrial transcripts
and aberrant processing of the precursors of the mitochondrial
transcripts. Therefore, SUV3 knock-out strains are respiratory
incompetent, show no mitochondrial translation and their
mitochondrial genomes are quickly lost (2±6).
Our recent data indicate that the yeast mitochondrial
degradosome is associated with mitochondrial ribosomes
and that RNA helicase activity of the complex precedes the
3¢®5¢ exoribonucleolytic activity. The physiological function
of the degradosome is not intron-related, the complex ensures
proper turnover of mitochondrial RNA (mtRNA) and is
involved in mtRNA surveillance (7).
In A.thaliana the AtSuv3p protein has a predicted molecular
weight of 63.6 kDa. Subcellular fractionation experiments
with transgenic plants allowed localisation of AtSuv3p to
mitochondria. The N-terminal domain of AtSuv3p contains
the motifs characteristic of RNA helicases and exhibits a low
endogenous ATPase activity in vitro which can be stimulated
by the presence of mtRNA (8). In C.elegans the activity of the
SUV3 orthologue was found to be necessary for survival of
early embryos (9).
Previously we cloned and initially characterised the cDNA
of the human orthologue of SUV3. The gene was named
SUPV3L1 and herein is referred to as hSUV3. We assigned
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hSUV3 to human chromosome band 10q22.1 by in situ
hybridisation (10). Sequence analysis showed that the hSuv3p
protein possesses a putative mitochondrial targeting sequence.
The human gene is expressed in all tissues analysed. The
highest levels of expression were found in liver and the lowest
in lung (11).
In this paper we present more detailed studies on human
hSuv3p. The protein was found to differ signi®cantly from its
yeast orthologue Suv3p. Using immuno¯uorescence, an
in vitro mitochondrial uptake assay and sub-fractionation of
human mitochondria we show that hSuv3p is localised in the
mitochondrial matrix and is not membrane bound, as in yeast.
Unexpectedly, enzymatic studies revealed that hSuv3p, in
addition to its previously predicted RNA helicase activity, has
much stronger DNA unwinding activity.
MATERIALS AND METHODS
Materials
DNA oligonucleotides were synthesised by Dr M. Schreiber
(Bernhard-Nocht Institute) or purchased from Sigma. RNA
oligonucleotides were purchased from HHMI Biopolymer/
Keck Foundation Biotechnology (Resource Laboratory, Yale
University School of Medicine). [g-32P]ATP (220 Tbq/mmol)
and [g-33P]ATP (110 Tbq/mmol) were from Hartmann
Analytic. 125I-labelled protein A (1.23 GBq/mg) was from
Amersham Pharmacia Biotech. All other chemicals were
obtained from Sigma.
Construction of plasmids
The pchSUV3myc and pcDmthSUV3myc plasmids used for
expression of wild-type hSuv3p and its mutated form without
the predicted mitochondrial targeting sequence in COS-1 and
HeLa cells were constructed as follows. Fragments of the
hSUV3 cDNA encoding the full-length hSuv3p protein
(2358 bp, 786 amino acids) or the form lacking the predicted
mitochondrial targeting sequence (2304 bp, 768 amino acids),
respectively, were PCR ampli®ed using the forward primer 5¢-
GCA TCT AGA CAC GAT GGC CTT CTC CCG TGC CCT
ATT GTG G-3¢ (for pchSUV3myc) or 5¢-CTA GTC TAG
AAT GGG CCA CCG GGC AGC CAT CTG C-3¢ (for
pcDmthSUV3myc), both introducing a XbaI site (underlined).
In both cases the reverse primer was 5¢-CGT GAA TTC ACA
GGT CCT CCT CGG AGA TCA GCT TCT GCT CGT CCG
AAT CAG GTT CCT TCT TC-3¢, introducing a c-myc (9E10)
epitope coding sequence (italic) and EcoRI site (underlined).
The pKK plasmid (11) containing a full-length cDNA clone of
the hSUV3 gene served as a template. The resulting fragment
was cloned into the XbaI and EcoRI sites of the pcDNA3.1(±)
vector (Stratagene).
For the biochemical characterisation of the hSUV3 gene
product and raising speci®c antibodies against hSuv3p, a
fragment of the protein devoid of 22 amino acids from the
N-terminus was expressed in Escherichia coli. The expression
plasmid pQEDmthSUV3his was constructed as follows. A
2292 bp fragment of the hSUV3 cDNA was ampli®ed by PCR
using the primers 5¢-TAC CCA TGG GCA TCT GCT CTG
CCC TTC G-3¢ (forward), introducing a NcoI site (under-
lined), and 5¢-CTG GGA TCC GTC CGA ATC AGG TTC
CTT C-3¢ (reverse), introducing a BamHI site (underlined),
using the pKK plasmid as a template. The resulting fragment
was cloned into the NcoI and BamHI sites of the pQE60
expression vector (Qiagen).
pQEDmthSUV3G207Vhis encoding mutated protein
hSuv3p(G207V) in which Gly207 was replaced by valine
was constructed employing a QuickChange Site-Directed
Mutagenesis Kit (Invitrogen) according to the manufacturer's
instructions and pQEDmthSUV3his plasmid as a template.
The following primers were used in site-directed mutagenesis:
forward, 5¢-TAA TAT TTC ATT CAG TCC CCA CAA ACA
GTG-3¢; reverse, 5¢-CAC TGT TTG TGG GGA CTG AAT
GAA ATA TTA-3¢ (substituted nucleotide underlined).
The sequences of all resulting constructs were veri®ed by
sequencing of both strands using an ABI Prism 377DNA
Sequencer.
Immuno¯uorescence experiments
Samples of 5 3 104 HeLa or COS-1 cells were plated per
well in 6-well plates (Costar) with a coverslip placed at
the bottom of the well and grown overnight in DMEM
(Sigma) supplemented with 10% FCS and 4 mM glutamine.
Immuno¯uorescence microscopy was performed as follows.
Twenty-four hours after transfection Mitotracker CMX-Ros
(300 nM) was added to the medium and incubated at 37°C for
30 min. Thereafter, the cells were washed three times with
phosphate-buffered saline (PBS), ®xed with 4% formaldehyde
in PBS for 15 min at 20°C and then permeabilised with 1%
Triton X-100 in PBS for 5 min. The cells were then incubated
with anti-hSuv3p serum (diluted 1:200 in PBS with 10% FCS)
(see below) for 1 h, washed in PBS and the bound antibody
was detected with ¯uorescein 5-isothiocyanate (FITC)-conju-
gated goat anti-rabbit IgG (1:200) (Molecular Probes).
Specimens were examined using a MRC Bio-Rad confocal
microscope.
In order to determine the subcellular localisation of the
overexpressed hSuv3p protein HeLa or COS-1 cells were
plated as described above and transiently transfected with
pchSUV3myc or pcDmthSUV3myc using FuGene6 reagent
(Roche). Detection of the protein was performed as described
above using anti-c-myc 9E10 monoclonal antibody (1:200)
(Santa Cruz Biotechnology), followed by incubation with
FITC-conjugated goat anti-mouse IgG (1:200) (Molecular
Probes).
Import of hSuv3p into isolated mitochondria
The in vitro import assay was performed essentially as
described by Tokatlidis (12). Brie¯y, yeast mitochondria
(100 mg protein) were incubated with 35S-labelled proteins
(synthesised in vitro using the rabbit reticulocyte lysate
system; Promega) for 15 min at 30°C in 200 ml of import
buffer (IB) containing 100 mM HEPES, pH 7.1, 1.2 M
sorbitol, 4 mM KH2PO4, 100 mM KCl, 20 mM MgCl2, 10 mM
L-methionine and 2 mg/ml fatty acid-free bovine serum
albumin supplemented with 5 mM NADH. Mitochondria were
harvested by centrifugation and resuspended in 100 ml of IB
supplemented with 0.1 mg/ml trypsin and incubated on ice.
After 30 min trypsin was inhibited by addition of soy bean
trypsin inhibitor to a concentration of 0.2 mg/ml and
incubation for 15 min on ice. In order to generate mitoplasts
by hypotonic swelling, mitochondrial pellets were resus-
pended in 30 ml of IB, diluted with 210 ml of 20 mM
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HEPES±KOH, pH 7.4, and incubated for 30 min on ice. After
centrifugation mitoplasts were precipitated from the super-
natant with TCA and resuspended in 100 ml of IB containing
30 mg/ml proteinase K. After 15 min incubation on ice
proteinase K was inhibited by incubating with 2 mM
phenylmethylsulphonyl ¯ouride (PMSF) for 10 min on ice.
For alkali extraction, mitoplasts were sedimented by centri-
fugation, resuspended in 100 ml of 100 mM Na2CO3, 2 mM
PMSF (ice-cold) and incubated for 30 min on ice. The
supernatant (matrix) and the pellet (membranes) were separ-
ated by centrifugation at 70 000 r.p.m. (TL100) for 30 min.
The matrix proteins were TCA precipitated and all the
fractions were resolved by SDS±PAGE, transferred to
nitrocellulose membranes and visualised by autoradiography
(Fuji Bas Station v.1.3). Subsequently the blots were analysed
using antibodies speci®c to endogenous yeast mitochondrial
proteins: anti-porin for the outer membrane, anti-mtHsp70p
for the matrix and anti-Cytb2 for the inter membrane space.
These antibodies were prepared against puri®ed yeast
mitochondrial proteins and originated from the laboratory
collection of Dr G. Schatz (also available in the laboratory of
K. Tokatlidis) (13).
Isolation and fractionation of mitochondria from HeLa
cells
Mitochondria were isolated as described by Gaines (14) with
the following modi®cations. Brie¯y, exponentially growing
HeLa cells (conditions as described above) were trypsinised,
washed twice in PBS and then twice with the washing buffer
(1 mM Tris±HCl, pH 7.0, 0.13 M NaCl, 5 mM KCl and 7.5 mM
MgCl2). The cell pellet (~1.5 ml) was resuspended in 0.75 ml
of 0.13 IB (4 mM Tris, pH 7.4, 2.5 mM NaCl and 0.5 mM
MgCl2) and homogenised using a Potter homogeniser. The
homogenate was immediately mixed with 0.17 ml of 103 IB.
The unbroken cells and nuclei were removed by three
consecutive low speed centrifugations (700 g for 3 min).
The remaining supernatant was centrifuged at 18 000 g for 2
min. The pelleted proteins served as a crude mitochondrial
fraction and the supernatant as a cytosolic fraction. The
identity of the cytosolic and mitochondrial fractions was
veri®ed by the presence of speci®c marker enzymes. When the
activity of lactate dehydrogenase in the starting cell homo-
genate was taken as 100%, 84±90% of the activity was
recovered in the cytosolic fraction as measured according to
the method described in Bergmeyer and Bernt (15). The
recovery of the matrix enzyme citrate synthase in the
mitochondrial fraction, measured as described in Graham
and Rickwood (16), was in the range 75±82%.
For sub-fractionation experiments the crude mitochondrial
fraction was further puri®ed. The crude mitochondria were
resuspended in TES buffer [10 mM Tris±HCl, pH 7.4, 1 mM
EDTA, 0.25 M sucrose supplemented with protease inhibitor
cocktail (Roche) and 2 mM PMSF], layered on a discontinu-
ous sucrose gradient made by successive layering of 1.5 M and
1.0 M sucrose and centrifuged at 60 000 g for 1 h. The phase
between the 1.5 and 1.0 M sucrose layers (mitochondrial
fraction) was collected and washed twice with TES buffer.
The sub-fractionation of mitochondria and preparation of
mitoplasts was described previously (17). Brie¯y, 3 mg of
freshly prepared mitochondria in 1 ml of TES were sonicated
and then centrifuged at 320 000 g for 1 h at 4°C. The
supernatant was TCA precipitated and used as the mitochon-
drial soluble fraction; the pellet served as the mitochondrial
membrane fraction. To obtain mitoplasts, mitochondria (3 mg)
in 0.3 ml of TES were diluted 10-fold with buffer containing
5 mM Tris±HCl, pH 7.4, and 1 mM EDTA and centrifuged at
14 000 g for 20 min at 4°C. The pellet was resuspended in 3 ml
of the same hypotonic buffer and left to stand on ice for 20 min.
The suspension containing mitoplasts was centrifuged at
14 000 g for 20 min at 4°C and washed three times with 3 ml
of the hypotonic buffer. All supernatants were pooled and
proteins were TCA precipitated. Sub-fractions were addition-
ally veri®ed by immunoblotting with antibodies speci®c to
human mitochondrial proteins: anti-Hsp60p (monoclonal
antibody purchased from Sigma) and anti-cytochrome c
(rabbit polyclonal antibody obtained from Santa Cruz
Biotechnology).
Puri®cation of hSuv3p
Escherichia coli strain DH5a transformed with
pQEDmthSUV3his or pQEDmthSUV3G207Vhis expression
plasmid (see Construction of plasmids) was cultured and
induced with isopropyl-b-D-thiogalactoside according to the
protocol for the QIAexpress Expression System (Qiagen).
In order to obtain the antigen for immunisation of rabbits
the hSuv3p protein was puri®ed under denaturing conditions
as follows. Bacteria were lysed at 100°C using a buffer
containing 6 M guanidine hydrochloride, 2% Triton-X, pH 8.0.
After binding to Ni±NTA resin the protein was eluted at
pH 4.2. The hSuv3p speci®c band was veri®ed by immuno-
blotting with anti-hexahistidine (his) tag monoclonal antibody
(not shown) and electroeluted from a polyacrylamide gel.
To study the biochemical properties of hSuv3p, the wild-
type or mutated form of the protein was puri®ed under non-
denaturing conditions as follows. After induction the bacteria
were collected by centrifugation and disrupted by sonication
in lysis buffer (100 mM Tris±HCl, pH 7.5, 20% glycerol, 0.1%
Triton X-100, 200 mM NaCl, 1 mM b-mercaptoethanol, 2 mM
PMSF and 10 mM imidazole). The insoluble material was
pelleted at 26 000 g and the supernatant was mixed with 3 ml
of nickel-charged resin (Qiagen) equilibrated with buffer
containing 20 mM Tris±HCl, pH 7.5, 10% glycerol, 0.05%
Triton X-100 and 1 mM b-mercaptoethanol for 12 h at 4°C.
The matrix was transferred onto a column and washed with the
same buffer supplemented with 200 mM NaCl and 20 mM
imidazole. The bound protein was eluted with the above buffer
containing 0.5 M imidazole. The purity of the obtained protein
was ~70% as judged by SDS±PAGE. The eluted fraction was
concentrated by ultra®ltration on a 30 kDa membrane
(Millipore) and fractionated on a Superdex-200 column (Hi-
Load; Amersham Pharmacia Biotech) equilibrated with TGT
buffer (20 mM Tris±HCl, pH 7.5, 10% glycerol, 0.05% Triton
X-100, 1 mM EDTA and 1 mM b-mercaptoethanol). Fractions
containing the highest ATPase and helicase activities were
pooled and analysed for the enzymatic properties of the
NTPase/helicase (storage in 30% glycerol at ±70°C). The
hSuv3p was >95% pure as judged by densitometric analysis of
Coomassie Blue stained polyacrylamide gels.
Raising antibodies
The puri®ed hSuv3p protein (200 mg) was mixed with
complete Freund's adjuvant and used for the immunisation
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of rabbits. Booster injections were performed using incom-
plete Freund's adjuvant, each of them about 1 month apart.
After the fourth injection ~50 ml of serum was taken, salted
out twice using 50% ammonium sulphate and the resulting
pellet resuspended and dialysed against PBS, pH 7.4. The
immunoreactivty of the serum prepared against hSuv3p was
veri®ed by immunoblotting. The total homogenate of HeLa
cells was immunoblotted and probed with the anti-hSuv3p
serum. The antibodies reacted with an 87 kDa protein (Fig. 4A,
lane 1). This corresponded to the molecular mass deduced
from the hSUV3 cDNA sequence. No signals were visible
when preimmune IgG was used (not shown).
ATPase assay
The ATPase activity was determined under conditions
described previously (18,19). Brie¯y, the enzyme (2 pmol)
was incubated in a reaction mixture (®nal volume 25 ml)
containing 20 mM Tris±HCl, pH 7.5, 2 mM MgCl2, 1 mM
b-mercaptoethanol, 10% glycerol, 0.01% Triton X-100, 0.1
mg/ml BSA, 25 nCi [g-33P]ATP and ATP adjusted to the
concentrations indicated in the ®gure legends (Fig. 8). The
reaction was carried out for 30 min at 30°C and terminated by
the addition of 0.75 ml of activated charcoal (2 mg/ml). After
incubation for 30 min at 30°C followed by centrifugation at
10 000 g for 10 min, 200 ml aliquots of the supernatant were
removed and subjected to scintillation counting.
Preparation of substrates for the helicase reaction
The substrates for the helicase reaction were obtained by
annealing two partially complementary DNA or RNA
oligonucleotides with the sequences reported by Gallinari
et al. (20). The release strand (26mer) was 5¢-end-labelled
with [g-32P]ATP by using T4 polynucleotide kinase (MBI
Fermentas) as recommended by the manufacturer. For the
annealing reaction the labelled oligonucleotide was combined
at a molar ratio of 1:10 with the template strand (40mer),
denatured for 5 min at 96°C and slowly renatured as described
previously (20). The resulting duplex was electrophoresed in a
15% native TBE polyacrylamide gel, visualised by autoradio-
graphy and extracted as described previously (21). The
amount of the DNA or RNA duplex used as substrate for the
NTPase/helicase was determined by an ethidium bromide
¯uorescent quantitation method described previously (22).
Helicase assay
The helicase activity was tested using 2 pmol (if not indicated
otherwise) hSuv3p protein. Unwinding of the partially
hybridised DNA or RNA substrate (4.7 pM) was allowed to
occur in a reaction mixture (®nal volume 25 ml) containing
20 mM Tris±HCl, pH 7.5, 2 mM MgCl2, 1 mM b-
mercaptoethanol, 10% glycerol, 0.01% Triton X-100, 0.1 mg/
ml BSA and ATP adjusted to a concentration corresponding to
the Km value determined for the ATPase reaction. The reaction
was carried out for 30 min at 30°C and stopped by addition of
8 ml of termination buffer (100 mM Tris±HCl, pH 7.5, 20 mM
EDTA, 0.5% SDS, 0.1% Triton X-100, 25% glycerol and
0.1% bromophenol blue). The samples were separated in a
15% Tris±borate±EDTA (TBE) polyacrylamide gel contain-
ing 0.1% SDS (23). The gels were dried and exposed to Kodak
X-ray ®lm at ±70°C. Subsequently, the parts of the gels
corresponding to the released strand and to not unwound
substrate were cut out and 32P radioactivity was measured.
Alternatively, the ®lms were scanned and the radioactivity
was quanti®ed using GelImage software (Amersham
Pharmacia Biotech).
Immunoblotting
After SDS±PAGE the proteins were transferred to nitro-
cellulose ®lters (BA 85, 0.45 mm; Schleicher & SchuÈll). The
®lters were incubated for 1 h with 1 mg/ml BSA in 25 mM
Tris±HCl, pH 7.5, 150 mM NaCl and 0.05% Tween-80 (TTBS
buffer) and for 2 h with antisera (1:500 in TTBS containing
10% glycerol and 3 mg/ml BSA). The ®lters were washed
again with 1 mg/ml BSA in TTBS and the bound antibodies
were detected by binding of [125I]protein A (0.05 mCi/ml) or
with rabbit anti-mouse antibodies followed by [125I]protein A.
The nitrocellulose ®lters were dried and subjected to
autoradiography.
Other assays
Protein concentration was determined by SDS±PAGE as
described previously (24) or using a Bio-Rad DC protein assay
kit with bovine serum albumin as a standard, according to
the manufacturer's instructions. Kinetic parameters were
determined by a non-linear regression analysis using
ENZFITTER (BioSoft) and SIGMA PLOT (Jandel Corp.).
Protein sequences of hSUV3 orthologues were aligned with
Gapped BLAST (v.2.0.10) with SEG and COIL ®ltering (25).
RESULTS
Subcellular distribution of hSuv3p
In order to determine the subcellular distribution of the
endogenous hSuv3p within mammalian cells we used a
polyvalent anti-hSuv3p rabbit serum prepared as described in
Materials and Methods. COS-1 and HeLa cells were stained
with the primary anti-hSuv3p serum and visualised with
FITC-conjugated secondary antibodies. Immuno¯uorescence
microscopy showed that the signal originating from hSuv3p
co-localised with the mitochondrial marker MitoTracker
CMXRos in both COS-1 and in HeLa cells (Fig. 1A). This
analysis also revealed faint nuclear staining patterns for both
of the examined cell types. However, when a control staining
with preimmune serum was carried out we could observe a
weak signal with a cytoplasmatic and nuclear pattern (not
shown). Therefore, we concluded that the majority of the
hSuv3p protein localises in mitochondria. In order to exclude a
possible double, nucleo-mitochondrial localisation, the
hSuv3p protein was C-terminally tagged with c-myc epitope
9E10 and its subcellular localisation was studied in transiently
transfected COS-1 and HeLa cells (Fig. 1B). The mitochon-
drial localisation was con®rmed by using the mitochondria-
speci®c dye MitoTracker CMXRos.
We used SignalP v.2.0 software (26) in order to predict the
presence and localisation of signal peptide cleavage sites in
the amino acid sequence of hSuv3p. The most probable
cleavage site of the mitochondrial leader in hSuv3p was found
between the residues at positions 18 and 19 (in the hSuv3p
sequence ¼RQA¯GH¼; cleavage site marked by arrow). We
constructed hSuv3p truncated N-terminally of 18 amino acids
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and incorporated a c-myc tag at the C-terminus. When this
tagged protein was transiently expressed in COS-1 and HeLa
cells, co-localisation with the mitochondrial marker
MitoTracker was signi®cantly reduced (Fig. 2). It therefore
appears that the N-terminal part of hSuv3p is responsible for
targeting of the protein to human mitochondria whilst the
protein lacking the mitochondrial targeting sequence is
retained in the cytoplasm.
Localisation of hSuv3p in the mitochondrial matrix
In order to determine the localisation of hSuv3p within
mitochondria yeast mitochondria were used. Published data
indicate that the transport machinery in yeast and human
mitochondria do not differ signi®cantly (27). Radiolabelled
hSuv3p synthesised in vitro using the rabbit reticulocyte
transcription and translation system was subjected to in vitro
Figure 1. Mitochondrial localisation of hSuv3p in mammalian cells. (A) COS-1 and HeLa cells were grown on coverslips, incubated with the
mitochondria-speci®c dye MitoTracker CMXRos (300 nM), ®xed with 4% formaldehyde and permeabilised with 1% Triton X-100. The cells were
immunostained with anti-hSuv3p serum and visualised with FITC-conjugated secondary antibody. Fluorescent images of MitoTracker (red) and hSuv3p
speci®c signal (green) were taken by a confocal microscope. Co-localisation of hSuv3p and mitochondria appear yellow in digitally overlaid images.
(B) COS-1 and HeLa cells were grown on coverslips and transiently transfected with cDNA encoding c-myc-tagged hSuv3p (pchSUV3myc). After incubation
with MitoTracker, ®xation and permeabilisation as described in (A), the cells were immunostained with anti-c-myc monoclonal antibody, which was then
visualised with FITC-conjugated antibody. Fluorescent images of MitoTracker (red) and c-myc-tagged hSuv3p (green) were taken by a confocal microscope.
Co-localisation of hSuv3p and mitochondria appear yellow in digitally overlaid images.
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mitochondrial import followed by fractionation of the
mitochondria into separate compartments. In parallel, mito-
chondrial uptake and fractionation of two well characterised
mitochondrial proteins, pSu9±DHFR and AAC, was per-
formed. pSu9±DHFR is a chimeric protein that contains the
®rst 69 amino acids of Neurospora crassa Fo-ATP synthase
subunit 9 fused to murine dihydrofolate reductase (DHFR).
After the import of pSu9±DHFR the pre-protein is cleaved,
liberating the mature form which localises in the mitochon-
drial matrix (28). AAC is an ADP/ATP carrier protein
localised in the mitochondrial inner membrane. In contrast
to pSu9±DHFR, AAC does not have a cleavable pre-sequence
and its targeting information is contained within its internal
sequence (29). When [35S]methionine-labelled hSuv3p was
incubated with yeast mitochondria the protein was transported
across the mitochondrial outer membrane and became
inaccessible to trypsin. AAC and mature pSu9±DHFR were
also imported and resistant to proteolysis. In contrast to this,
hSuv3p without the mitochondrial targeting sequence (see
above) was not imported into the mitochondria and hence was
susceptible to the added protease (Fig. 3A, lane 1). To sub-
fractionate mitochondria the outer membrane was disrupted
by osmotic shock, which released components of the inter-
membrane space. The resulting mitoplasts were additionally
treated with proteinase K. Under these conditions full-length
hSuv3p along with mature pSu9±DHFR and AAC remained
associated with the mitoplast pellet and were protected from
proteinase K enzymatic digestion (Fig. 3A, lanes 2 and 3). No
hSuv3p was detected in the intermembrane space fraction
(Fig. 3A, lane 6). Alkali extraction of the mitoplasts with
Na2CO3 showed that hSUV3p was imported mainly into the
mitochondrial matrix and is not embedded in the membrane,
just like mature pSu9±DHFR (Fig. 3A, lane 4), whereas AAC
was inserted into the inner membrane (Fig. 3A, lane 5). The
submitochondrial fractionation after hSuv3p import was
con®rmed by immunoblotting using antibodies against
endogenous marker mitochondrial proteins localised in dif-
ferent mitochondrial subcompartments: anti-porin for the
outer membrane, anti-mtHsp70p for the matrix and anti-
Cytb2 for the inter-membrane space (Fig. 3B) (13).
In order to con®rm the localisation of hSuv3p in the
mitochondrial matrix in human cells the sub-fractions of
mitochondria from HeLa cells were examined for the presence
of hSuv3p by immunoblotting using the anti-hSuv3p serum.
The hSuv3p-speci®c band was detected predominantly in the
crude mitochondrial fraction (Fig. 4A, lane 1). Subsequently
puri®ed human mitochondria were sub-fractionated into
membrane and soluble fractions. When the submitochondrial
fractions were examined by immunoblotting, the hSuv3p-
speci®c band was detected almost exclusively in the soluble
fraction, along with the mitochondrial matrix protein Hsp60p,
which was used as a marker (30) (Fig. 4B, lane 3). Soluble
mitochondrial fraction contained both matrix and inter-
membrane space components. Therefore, to investigate
whether mitochondrial hSuv3p is localised in the inter-
membrane space or in the matrix, mitoplasts and the post-
mitoplast supernatant were analysed by immunoblotting.
hSuv3p was retained exclusively in the mitoplasts, similarly
to Hsp60p matrix marker protein (Fig. 4C, lane 3).
Cytochrome c, an inter-membrane space marker protein
(31), was recovered in the post-mitoplast supernatant
(Fig. 4C, lane 2). These results indicate that hSuv3p is
localised in the matrix of human mitochondria.
Heterologous production and enzymatic properties of
hSuv3p
In order to study the biochemical properties of hSuv3p protein,
the cDNA encoding the polypeptide consisting of 764 amino
Figure 2. N-terminal sequence is necessary for the mitochondrial import of the hSuv3p protein. COS-1 and HeLa cells were grown on coverslips and
transiently transfected with cDNA encoding N-terminally truncated (the ®rst 18 amino acids) hSuv3p with a c-myc tag at the C-terminus (pcDmthSUV3myc).
After incubation with the mitochondria-speci®c label MitoTracker CMXRos (300 nM), ®xation with 4% formaldehyde and permeabilisation with 1% Triton
X-100 the cells were immunostained with anti-c-myc monoclonal antibody. The c-myc-tagged N-terminally truncated hSuv3p was visualised with
FITC-conjugated antibody (green); the mitochondria stained with MitoTracker are red. The hSuv3p protein devoid of the 18 N-terminal amino acids did not
co-localise with the mitochondria in either COS-1 or HeLa cells.
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acid residues (hSuv3p without the ®rst 22 N-terminal amino
acids) fused to a his tag at its C-terminus was expressed
in E.coli. After disruption of the bacteria, the pool of
enzyme present in the Triton X-100 solubilised fraction
was puri®ed by Ni2+ af®nity chromatography under non-
denaturing conditions. In addition to the expected 87 kDa
protein, the imidazole-eluted fraction contained an induction-
speci®c protein that migrated at ~55 kDa and some back-
ground of bacterial proteins (Fig. 5A, lane 2). The 87 and
55 kDa polypeptides were not present in a similar fraction
prepared from non-induced bacteria or from induced bacteria
harbouring empty pQE60 plasmid (not shown).
In order to separate the 87 and 55 kDa polypeptides and to
remove the contaminating proteins gel ®ltration chromato-
graphy on Superdex-200 was employed. The elution pro®le
was monitored by ATPase and helicase assays (see below).
Both enzymatic activities migrated in two peaks: the ®rst one
at the void volume of the column and the second one
corresponding to proteins migrating at 80±90 kDa (Fig. 5B).
The void volume fraction analysed by SDS±PAGE contained
a mixture of both 55 and 87 kDa proteins (not shown). The
second peak of the ATPase and helicase activities consisted of
a homogeneous preparation of a protein with an apparent
molecular mass of 87 kDa, which is in agreement with the
predicted molecular mass of monomeric form hSuv3p-his
protein (86.4 kDa) (Fig. 5A, lane 3).
The identity of the puri®ed protein was veri®ed by
immunoblotting with anti-hSuv3p antiserum and with anti-
his tag antibody (Fig. 5C, lanes 1 and 2, respectively). The
identity of the 55 kDa protein could also be determined.
The protein was reactive with both antibodies, i.e. with anti-
hSuv3p serum and with anti-his tag antibody, in immunoblots
(data not shown). Since the his tag was attached to the C-
terminus of hSuv3p protein we concluded that the 55 kDa
protein represented the N-terminally degraded fragment of the
intact 87 kDa polypeptide.
The above puri®cation procedure was applied to the E.coli
strain expressing the hSuv3p mutant with the replacement of
Gly207 by valine [named hSuv3p(G207V)] within the N-
terminus of the Walker A motif (32). An analogous replace-
ment performed on previously described NTPase/helicases
abolished their ATPase activity (33,34). As expected, for the
hSuv3p(G207V) mutant protein neither ATPase nor helicase
activity for either double-stranded (ds)DNA or dsRNA could
be detected after gel ®ltration chromatography. Figure 6
presents data obtained with the dsDNA substrate.
Figure 3. The hSuv3p protein imported into isolated yeast mitochondria is
localised in the mitochondrial matrix. (A) In vitro synthesised radiolabelled
proteins, hSuv3p (wild-type), pSu9±DHFR (localised in the mitochondrial
matrix), AAC (localised in the mitochondrial inner membrane) and
DmthSuv3p (hSuv3p protein devoid of the 18 N-terminal amino acids),
were incubated with isolated yeast mitochondria. After import, mitochondria
were treated with protease (trypsin) to remove non-imported precursor (lane
1). In the next step the mitoplasts were prepared by osmotic shock (lane 2)
and treated with proteinase K (lane 3). After alkali extraction of the
mitoplasts with Na2CO3 the soluble fraction (lane 4) and the membrane
pellets (lane 5) were analysed. The inter-membrane space fraction released
after osmotic swelling was also examined (lane 6). All the protein samples
were separated by SDS±PAGE, transferred onto nitrocellulose membranes
and visualised by autoradiography. For pSu9±DHFR arrows indicate the
precursor (P) and mature peptide cleaved by mitochondrial MPP (M).
Asterisks show the protease-resistant fragment of the protein AAC inserted
into the mitochondrial inner membrane. The 10% of the input is also
shown. (B) The mitochondrial fractions transferred onto nitrocellulose
membranes after the import of hSuv3p from (A) were veri®ed by immuno-
blotting with antibodies speci®c to the endogenous proteins localised in
different mitochondrial subcompartments: anti-porin for the outer membrane
(a porin), anti-mtHsp70p for the matrix (a mtHsp70p) and anti-Cytb2 for
the inter-membrane space (a Cytb2).
Figure 4. Localisation of the hSuv3p protein in the mitochondrial matrix of
human mitochondria. (A) Crude mitochondrial fraction (lane 1), cytosolic
fraction (lane 2) and total cell extract (lane 3) of HeLa cells were separated
by SDS±PAGE, immunoblotted and probed with the anti-hSuv3p serum
(a hSuv3p). (B) Soluble submitochondrial fraction (lane 1), membrane
submitochondrial fraction (lane 2) and total extract of puri®ed mitochondria
of HeLa cells (lane 3) were immunoprobed with the anti-hSuv3p serum
(a hSuv3p) as above. (C) Mitoplasts (lane 1), post-mitoplast supernatant
(lane 2) and total extract of puri®ed mitochondria of HeLa cells (lane 3)
were separated by SDS±PAGE, immunoblotted and probed with the
anti-hSuv3p serum (a hSuv3p). Subcellular and submitochondrial fractions
were veri®ed by immunoblotting with antibodies speci®c to the endogenous
proteins localised in different mitochondrial subcompartments: anti-Hsp60p
for the matrix (a Hsp60p) and in (C) anti-CytC for the intermembrane
space (a CytC). Molecular masses are indicated on the left-hand side of the
blot images.
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The anti-hSuv3p antibody reacting with the 87 kDa protein
in the immunoblot was capable of inhibiting the enzymatic
activities associated with the enzyme when diluted 1:30. The
helicase activity was determined with both dsDNA and
dsRNA substrate (Fig. 7A). The negative sera failed to affect
these enzymatic activities (Fig. 7B).
The above results con®rm that the puri®ed recombinant
87 kDa wild-type hSuv3p protein showing anti-hSuv3p and
anti-his tag immunoreactivity represented the only NTPase/
helicase present in the enzyme preparation.
Characterisation of the biochemical properties of the
hSuv3p NTPase/helicase
Analysis of the amino acid sequence of hSuv3p protein
revealed motifs that are typical for helicases and suggested
that the protein might be an RNA helicase (35,36). Thus,
further experiments were performed to characterise the
NTPase activity and unwinding activities of the protein.
These investigations were performed with the 87 kDa
polypeptide present in the fractions obtained from the
Superdex-200 column corresponding to the monomeric form
of the protein.
The ATPase activity of the enzyme was monitored in a
standard assay by determination of the 33Pi released from
[g-33P]ATP due to enzyme-mediated hydrolysis as described
in Materials and Methods. Using this method we estimated the
optimum reaction conditions for the ATPase activity of
hSuv3p NTPase/helicase. The optimal ATP hydrolysis was at
30°C. The monovalent cations Na+ and K+ did not exert any
effect on the ATPase activity of the enzyme up to a
concentration of 150 mM. Higher salt concentrations inhibited
ATP hydrolysis with IC50 values of 280 and 200 mM for Na+
and K+, respectively. The ATPase activity of the hSuv3p
NTPase/helicase was tested as a function of increasing
concentrations of the divalent ions Mg2+ and Mn2+. The two
metal cations revealed optimal activity of the protein at
1±5 mM for Mg2+ and 0.2±1 mM for Mn2+. Under the
optimised reaction conditions the Lineweaver±Burk plot was
linear up to ATP concentrations of 100 mM and yielded a Km
value of 41.9 mM. At saturating concentrations of ATP 1 mol
of the enzyme hydrolysed 0.32 mol ATP per second.
An interesting phenomenon was observed when the ATPase
activity of the enzyme was measured in the presence of 1-b-D-
ribofuranosyl-1,2,4-triazole-3-carboxamide-5¢-triphosphate
(ribavirin-TP). Ribavirin-TP was previously reported to
inhibit hepatitis C virus (HCV) NTPase/helicase (19). At
lower ATP concentrations (<<Km) ribavirin-TP exerted a
strong inhibitory effect on the ATPase activity of the hSuv3p
NTPase/helicase. Reduction of the ATP concentration
increased the inhibitory effect of ribavirin-TP. Thus, at an
ATP concentration of 1 3 10±5 3 Km (42 nM) an IC50 of
3±5 mM was measured. On the other hand, increasing the ATP
Figure 5. Puri®cation of hSuv3p from E.coli. (A) SDS±PAGE analysis of
puri®cation steps. Triton X-100 soluble fraction (lane 1); Ni2+ af®nity
chromatography (lane 2); Superdex-200 column (lane 3). The samples were
separated by SDS±PAGE and the proteins stained with Coomassie Blue.
M(r) kDa, molecular mass markers in kilodaltons. (B) Gel ®ltration
puri®cation of hSuv3p. The distribution of protein and of NTPase and
helicase activities of the hSuv3p preparation obtained by Ni2+ af®nity
chromatography on an analytical Superdex-200 column is shown. The
NTPase and the helicase assays were performed as described in Materials
and Methods. In the case of the helicase assay a dsDNA substrate was used.
The column was calibrated with dextran blue (DB) (2000 kDa) and with the
following marker proteins: IgG (160 kDa); PB, phosphorylase b (97 kDa);
BSA (66 kDa); OV, ovalbumin (45 kDa); CA, carbonic anhydrase (30 kDa).
(C) Aliquots of pooled fractions from the Superdex-200 column displaying
ATPase and helicase activity were removed and precipitated with TCA.
Samples were separated by SDS±PAGE followed by immunoblotting with
anti-hSuv3p antiserum (lane 1) and with anti-his tag antibody (lane 2). The
nitrocellulose ®lters were autoradiographed for 24 h. M(r) kDa, molecular
mass markers in kilodaltons. The arrow indicates the position of hSuv3p.
Figure 6. Lack of the NTPase and helicase activity of hSuv3p mutated in
the Walker A motif. An aliquot of 2 pmol of homogeneously puri®ed
hSuv3p wild-type enzyme (lane 3) and its mutated form hSuv3p(G207V)
(lane 4) was allowed to react with a dsDNA substrate (4.7 pM) as described
in Materials and Methods. The substrate and released strand were separated
in a TBE polyacrylamide gel and visualised by exposure of the dried gel to
X-ray ®lm for 24 h.
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concentration in the reaction mixture reduces the inhibitory
effect of ribavirin-TP. At ATP concentrations corresponding
to the Km value ribavirin-TP does not inhibit and even
activates ATP hydrolysis. Increasing the ATP concentration
could further enhance this activating effect. For example, at an
ATP concentration equal to 100 3 Km (4.2 mM) and 300 mM
ribavirin-TP an activation of 250% was measured.
Analogous results were obtained with a range of slowly
hydrolysed or non-hydrolysable nucleoside 5¢-triphosphate
analogues, like adenosine 5¢-g-thiotriphosphate (ATP-g-S), 5¢-
adenylimidodiphosphate (AMP-PNP) and b,g-methyleneade-
nosine 5¢-triphosphate (AMP-PCP). All the compounds tested
were potent inhibitors of the enzyme at lower ATP concen-
trations, while having an activating effect at higher ATP
concentrations with the following order of ef®ciency: ATP-g-
S < AMP-PCP < AMP-PNP. Figure 8A presents the modu-
lation of the ATPase activity by AMP-PNP measured at
different ATP concentrations. Analysis of the AMP-PNP-
mediated inhibition, measured at strongly reduced ATP
concentrations, by mean of a graphic method (37) revealed
pure competitive inhibition with regard to ATP (Fig. 8B).
A common property of numerous NTPase/helicases is their
activation and even dependency of the ATPase activity on
RNA, DNA or homopolymeric polynucleotides (36 and
references therein). Under optimal reaction conditions we
analysed the effect of various ribo- and deoxyribonucleotides
on the ATPase activity of the hSuv3p NTPase/helicase.
However, in contrast to the enzymes described previously the
ATPase activity of hSuv3p protein is only moderately affected
by the polynucleotides tested; the highest activation was
observed with poly(U) (140% of control) and DNA (120% of
control) with optimum concentrations of 330 and 120 mM of
nucleotide base, respectively.
The unwinding activity of hSuv3p protein was monitored
and characterised with RNA and DNA substrates. Both
substrates consisted of two partially hybridised oligonucleo-
tides; a 26mer, the release strand, and a 40mer, the template
strand. The same substrates were previously used to charac-
terise the helicase activity of West Nile virus (WNV) and
HCV NTPase/helicases (20,23,38). The hSuv3p enzyme was
found to be capable of unwinding DNA/DNA and RNA/RNA
homoduplexes (Fig. 9, lanes 3 and 10). To compare the
catalytic ef®ciency of the unwinding activity of hSuv3p
NTPase/helicase towards RNA and DNA substrates we
performed a strand displacement experiment in which
decreasing concentrations of enzyme were added at the
constant non-saturating concentration of 4.7 pM of RNA or
DNA substrate. Although the hSuv3p NTPase/helicase separ-
ated the dsDNA with an ~10 000 higher activity compared to
dsRNA, it unwound 95% of the DNA substrate but 100% of
RNA substrate (Fig. 9).
DISCUSSION
Proteins involved in mitochondrial mRNA processing and
degradation in humans have yet to be characterised. In
S.cerevisiae RNA turnover is mediated by a 3¢®5¢ exoribo-
nuclease complex known as the mitochondrial degradosome,
mtEXO (39). Previously we cloned the cDNA coding for the
human orthologue of the putative yeast RNA NTPase/helicase
Suv3p, a component of the yeast mitochondrial degradosome
(11). Both yeast and human proteins display high homology
(35% identity, 53% similarity over 567 residues), but
sequence similarity does not allow prediction of the precise
function of the human orthologue. The properties of the
human protein may have been modi®ed during the course of
evolution and in humans hSuv3p might be now associated
with different molecular mechanisms.
Figure 8. Modulation of the ATPase activity of hSuv3p by AMP-PNP with
variations in ATP concentration. (A) Investigation of the ATPase activity as
a function of increasing concentrations of AMP-PNP in the presence of dif-
ferent ATP concentrations. The demonstrated assays were performed at
ATP concentrations of hSuv3p ATPase (41.9 mM) equal to (diamond) 100
3 Km; (triangle) 1 3 Km; (square) 0.001 3 Km; and (circle) 0.00001 3 Km.
The activities of the enzyme measured for each ATP concentration in the
absence of AMP-PNP was referred to as 100%. (B) Kinetic analysis of the
inhibition of the hSuv3p ATPase at lower ATP concentrations. Data ob-
tained at ATP concentrations equal to (circle) 0.00001 3 Km, (open tri-
angle) 0.00003 3 Km and (open square) 0.0001 3 Km were replotted
according to the method of Dixon (37).
Figure 7. Depletion of enzymatic activities of hSuv3p NTPase/helicase by
anti-hSuv3p antibodies. Aliquots of the puri®ed hSuv3p NTPase/helicase
(2 pmol) were incubated with anti-hSuv3p serum (A) or with preimmune
serum (B) at 30°C for 30 min, then adjusted to the concentrations indicated
in the ®gure. Thereafter the unwinding or ATPase reactions were started
and the samples were processed as described in Materials and Methods.
Values for the enzymatic activities are shown as means 6 SEMs for
representative experiments performed in triplicate.
5082 Nucleic Acids Research, 2002, Vol. 30, No. 23
 at Periodicals D
ept on M
ay 31, 2013
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
There are indications that the metazoan SUV3 gene is
indispensable for proper cellular function. The data obtained
in a large-scale analysis of SUV3 function in C.elegans (47%
identity and 65% similarity over 669 residues on the protein
level between C.elegans and H.sapiens) by high throughput
RNAi showed that inactivation of the gene caused embryo
development to arrest 24 h post-inactivation (9). In addition,
no rearrangements have been found in the band 10q22.1 of
human chromosome 10, to which the hSUV3 gene was
assigned (40). This could be an indication that hSuv3p in its
intact functional form is also essential for human cells.
In order to investigate the possible function of hSuv3p we
decided ®rst to analyse the precise cellular localisation of
hSuv3p in mammalian cells and to study the enzymatic
activity of the protein in vitro.
Most mitochondrial proteins are encoded by the nuclear
genome and thus have to be synthesised in the cytosol and then
imported into mitochondria. Protein translocation across and
into the mitochondrial membranes is a multistep process
facilitated by the coordinated action of specialised trans-
location systems in the outer and inner membranes of
mitochondria (41). Previous analysis of hSuv3p for the
presence of a mitochondrial targeting sequence indicated
that hSuv3p might be imported into mitochondria (11).
However, the localisation of the protein in vivo in human
cells remained to be shown. Immuno¯uorescence microscopy
clearly demonstrates that hSuv3p is localised in mitochondria
of human and simian cells. The N-terminal part of hSuv3p was
also shown to be necessary for mitochondrial import, since a
mutant form of hSuv3p lacking the 18 residues at the N-
terminus was not targeted to the mitochondria.
The classical mitochondrial targeting N-terminal pre-
sequences consist of positively charged, hydrophobic and
hydroxylated amino acids that can form an amphiphilic
a-helix and function as a matrix-targeting signal. However,
pre-sequence-like signals are also used by several pre-proteins
that are destined for the three other mitochondrial subcom-
partments: the outer membrane, the inter-membrane space and
the inner membrane. In these cases the pre-sequences are
complemented by other sorting signals that lead to a speci®c
arrest of the pre-proteins in the respective compartment (stop-
transfer signals) (13). The presence of a functional mitochon-
drial targeting presequence on the N-terminus and the lack of
other predicted sorting signals (e.g. a hydrophobic membrane
anchor) suggested that hSuv3p is imported to the mito-
chondrial matrix space. Two sets of experiments support this
point: (i) an import assay into isolated yeast mitochondria
followed by separation of mitochondrial subcompartments;
(ii) immunoblotting of human mitochondrial subfractions with
hSuv3p speci®c antiserum. Using yeast mitochondria to study
the import of human proteins has been reported previously
(42,43).
A number of yeast mitochondrial proteins have their
homologues in human mitochondria. Thus, S.cerevisiae is
considered as a particularly suitable simple organism widely
used for studying the function of human proteins (44).
However, because of differences in mitochondrial DNA
organisation and expression between human and yeast
mitochondria, it cannot be assumed a priori that given
orthologues play identical biological functions. For example,
in mitochondrial DNA replication orthologic DNA poly-
merases (45) but unrelated DNA helicases are involved in
yeast and humans. Human mitochondria contain a T7-related
DNA helicase (46) that has no orthologue in yeast.
The results presented suggest important differences be-
tween the human and yeast SUV3 gene products. hSuv3p was
shown to be a soluble protein localised in the human
mitochondrial matrix space, whereas our recent experiments
have revealed that in yeast mitochondria the complex
consisting of Suv3p helicase and Dss1p RNase is associated
with mitochondrial ribosomes (37), which are thought to be
associated with the inner membrane (47). Additionally, no
orthologue of Dss1p has been found in the human genome and
we were not able to complement the yeast SUV3 knock-out by
its human orthologue (not shown), although hSuv3p is
properly imported into yeast mitochondria in vitro. These
results suggest that in humans, in spite of high conservation
through evolution, hSuv3p might be involved in different
mitochondrial processes than its yeast counterpart.
For most proteins de®ned as NTPase/helicases on the basis
of their amino acid sequences, no biochemical studies have
been performed. Up to now there were also no data about the
enzymatic activity of hSuv3p. Analysis of the amino acid
sequence of the protein revealed a range of conserved motifs,
which are associated with NTP and/or polynucleotide binding
characteristic of NTPase/helicases (35,48,49). The best con-
served are motifs I and II, the so-called `Walker motifs A and
B', that are present in all NTPase/helicases as well as in a wide
variety of other NTP-utilising proteins. The functions of these
motifs, which compose the NTP-binding pocket of the
proteins, are association of the terminal phosphate groups of
NTP (Walker motif A) and chelatation of the Mg2+ of the Mg-
NTP complex (Walker motif B) (32). There are a number of
reasons to classify hSuv3p in superfamily 1 (SFI) of NTPase/
helicases: (i) the amino acid sequence of the hSuv3p Walker A
Figure 9. Comparison of ef®cacy of RNA and DNA unwinding reaction
mediated by hSuv3p as a function of decreasing enzyme concentration. The
reaction mixture was composed as described in Materials and Methods with
various hSuv3p enzyme concentrations used: 0.66 fM (lanes 2 and 8); 66 fM
(lanes 3 and 9); 6.6 pM (lanes 4 and 10); 0.66 nM (lanes 5 and 11); 66 nM
(lanes 6 and 12). The substrate and released strand were separated in a TBE
polyacrylamide gel and visualised by exposure of the dried gel to X-ray
®lm for 24 h. The results shown are representative of three independent
experiments.
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motif (G-P-T-N-S-G-K-T) is characteristic of DNA SFI
NTPase/helicases (35,36,48); (ii) the presence of a hydro-
phobic isoleucine residue within the Walker B motif (35); (iii)
lack of a typical SAT motif, unique to SF2 NTPase/helicases.
Membership of a particular superfamily has, however, no clear
predictive value regarding the key properties of the enzymes
(35,36).
The hSuv3p enzyme utilises both RNA and DNA substrates
with a strong preference for the latter. To our knowledge there
are only a few NTPase/helicases that show an exclusive RNA
or DNA speci®city. The explanation for this lack of speci®city
might be the fact that the interaction between the protein
molecule and the DNA or RNA substrate is mainly mediated
by phosphate groups and not by the nucleotide base or sugar
moieties (50±52). Although hSuv3p protein was previously
referred to as a putative RNA NTPase/helicase (11), the
sequence characteristics mentioned above characterise the
protein rather as a DNA enzyme. Our enzymatic data show
that hSuv3p unwinds dsDNA 104 times more ef®ciently than
dsRNA. This seems to be in contrast to yeast Suv3p protein,
which was shown to function as an RNA helicase participating
in RNA degradation and 3¢ and 5¢ processing of mtRNA. The
observed reaction rates for the enzyme/substrate ratios used in
our experiments are similar to published results obtained for
in vitro helicase assays (53). It is obvious, however, that
characteristics of a recombinant protein in an in vitro assay
may differ from those in vivo. We do not know yet if hSuv3p
protein forms a complex with another protein(s) in mitochon-
dria and what its physiological function is. The observed
strong preference for dsDNA substrates might indicate the
participation of hSuv3p in DNA replication, but more research
is needed to prove this hypothesis.
The NTPase/helicase nature of hSuv3p was veri®ed by site-
directed mutagenesis experiments in which Gly207 was
replaced by valine. The Gly207 residue represents the N-
terminus of the Walker A motif (see above). As mentioned
above, the glycine residue in the ®rst position of the Walker A
motif is highly conserved between DNA NTPase/helicases of
SF1 and numerous ATPases and GTPases, whereas RNA
NTPase/helicases have in most cases an alanine in this
position (36,54,55). Substitution of alanine by glycine in the
translation factor Tif1 from S.cerevisiae was shown to have no
effect on the growth rate (33). An analogous exchange
performed on the eukaryotic translation initiation factor 4A
(eIF-4A) RNA NTPase/helicase even increased its ATP
binding capacity (34). Such an effect could be expected
since both amino acids have uncharged and unbranched side
chains. However, the introduction of the isopropyl moiety of
valine in this position causes dramatic inhibition of the
functions of the RNA helicase activity in the translation factor
Tif1 from S.cerevisiae and is lethal for the cells (33). The
respective substitution dramatically reduces ATP binding by
the eIF-4A RNA NTPase/helicase (34). Also, for hSuv3p
replacement of the glycine of the Walker A motif with valine
abolished both the ATPase and helicase activities of the
enzyme.
In the helicase assays the hSuv3p enzyme was added in a
vast excess over the substrate, therefore one could speculate
that the unwinding reaction mediated by hSuv3p would be
non-enzymatic. This possibility is, however, excluded by the
experiments with a mutated protein, hSuv3p(G207V), which
could not utilise ATP. The mutated protein was unable to
separate the dsDNA or dsRNA substrates. Additionally,
corroborating this are our observations with a second mutant
enzyme in which the Walker motif B (32), DEIQ, was
replaced by DAIQ [hSuv3p(E292A) mutant]. The protein was
not able to hydrolyse ATP and to separate dsDNA or dsRNA
used as substrates (manuscript in preparation).
The majority of the NTPase/helicases characterised to date
exhibit polynucleotide-dependent and polynucleotide-inde-
pendent NTPase activities (56). The enzymes differ dramat-
ically in the extent of nucleic acid-induced stimulation of their
NTPase activity. For example, poly(rU) enhanced the kcat
value of HCV ATPase up to 30-fold (56). In contrast, the
ATPase activities of bacterial helicases such as Rep and
helicase II are increased over 1000-fold by single-stranded
DNA (57). In contrast, the hSuv3p ATPase activity displays
rather modest stimulation by polynucleotides (1.4-fold). The
weak response of hSuv3p to nucleic acids is, however, not
unique. There are several known viral NTPase/helicases
whose ATPase activity is stimulated only weakly by
polynucleotides (23,35). This apparent difference might result
from different reaction conditions used; differences in purity
of the enzyme preparation or source of the enzyme
(19,37,56,58±60). On the other hand it is possible that in vivo
a speci®c RNA or DNA cofactor(s) exists, as for the ATPase
activity of protein Slt22p (61), that in the case of hSuv3p
remains to be discovered.
Non-hydrolysable ATP analogues are effective inhibitors of
the NTPase activity of the hSuv3p enzyme, although the
inhibition occurred only at low ATP concentrations. Higher
concentrations of ATP abolished the inhibition and even
stimulated the hydrolytic activity of the enzyme. A possible
explanation of this phenomenon is that hSuv3p protein has two
binding sites for nucleosides and nucleotides, as previously
postulated for the HCV enzyme (62). The ®rst one is equipped
with Walker motifs (where the ATP normally binds) and is,
therefore, more speci®c for nucleoside 5¢-triphosphate sub-
strates. The second could be an allosteric binding site less
speci®c for nucleosides or nucleotides. According to this
hypothesis, at low ATP concentrations (less than the Km value
of the speci®c NTPase reaction) ribavirin-TP, as well as other
nucleoside 5¢-triphosphate analogues, competes against ATP
for the ®rst site containing Walker motifs and thus causes
competitive inhibition of the NTPase. At high concentrations
of ATP along with ribavirin-TP or nucleoside 5¢ triphosphate
analogues the second site becomes more and more occupied
and there is a consequent conformational change occurring in
the NTPase, which ultimately leads to its activation. A similar
pattern of interaction of ATP, ribavirin-TP and NTPase/
helicase was previously described by us for some members of
SFII family of enzymes, like HCV and WNV NTPase/helicase
(19,23).
In conclusion, we biochemically characterised the nuclear
encoded RNA and DNA helicase present in the mitochondrial
matrix of human mitochondria. Our results indicate that the
human enzyme signi®cantly differs from its yeast orthologue.
While from numerous studies in different laboratories the
involvement of yeast Suv3p in RNA turnover seems to be very
well proven, the human protein shows a strong preference for
dsDNA and is present exclusively in the mitochondrial matrix.
Further research is in progress to answer the question whether
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hSuv3p protein is part of the mitochondrial RNA degrading
machinery or has acquired new features during evolution.
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